Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals

Background: Measuring a country's health performance has focused mostly on estimating levels of mortality. An alternative is to measure rates of decline in mortality, which are more sensitive to changes in health policy than are mortality levels. Historical rates of decline in mortality can als...

Full description

Bibliographic Details
Main Authors: Dr. Stéphane Verguet, PhD, Prof. Ole Frithjof Norheim, PhD, Zachary D Olson, MA, Gavin Yamey, MD, Prof. Dean T Jamison, PhD
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X1470316X
_version_ 1828434926271201280
author Dr. Stéphane Verguet, PhD
Prof. Ole Frithjof Norheim, PhD
Zachary D Olson, MA
Gavin Yamey, MD
Prof. Dean T Jamison, PhD
author_facet Dr. Stéphane Verguet, PhD
Prof. Ole Frithjof Norheim, PhD
Zachary D Olson, MA
Gavin Yamey, MD
Prof. Dean T Jamison, PhD
author_sort Dr. Stéphane Verguet, PhD
collection DOAJ
description Background: Measuring a country's health performance has focused mostly on estimating levels of mortality. An alternative is to measure rates of decline in mortality, which are more sensitive to changes in health policy than are mortality levels. Historical rates of decline in mortality can also help test the feasibility of future health goals (eg, post-2015). We aimed to assess the annual rates of decline in under-5, maternal, tuberculosis, and HIV mortality over the past two decades for 109 low-income and middle-income countries. Methods: For the period 1990–2013, we estimated annual rates of decline in under-5 mortality (deaths per 1000 livebirths), the maternal mortality ratio (deaths per 100 000 livebirths), and tuberculosis and HIV mortality (deaths per 100 000 population per year) using published data from UNICEF and WHO. For every 5-year interval (eg, 1990–95), we defined performance as the size of the annual rate of decline for every mortality indicator. Subsequently, we tested the feasibility of post-2015 goals by estimating the year by which countries would achieve 2030 targets proposed by The Lancet's Commission on Investing in Health (ie, 20 deaths per 1000 for under-5 mortality, 94 deaths per 100 000 for maternal mortality, four deaths per 100 000 for tuberculosis mortality, and eight deaths per 100 000 for HIV mortality) at observed country and aspirational best-performer (90th percentile) rates. Findings: From 2005 to 2013, the mean annual rate of decline in under-5 mortality was 4·3% (95% uncertainty interval [UI] 3·9–4·6), for maternal mortality it was 3·3% (2·5–4·1), for tuberculosis mortality 4·1% (2·8–5·4), and for HIV mortality 2·2% (0·1–4·3); aspirational best-performer rates per year were 7·1% (6·8–7·5), 6·3% (5·5–7·1), 12·8% (11·5–14·1), and 15·3% (13·2–17·4), respectively. The top two country performers were Macedonia and South Africa for under-5 mortality, Belarus and Bulgaria for maternal mortality, Uzbekistan and Macedonia for tuberculosis mortality, and Namibia and Rwanda for HIV mortality. At aspirational rates of decline, The Lancet's Commission on Investing in Health target for under-5 mortality would be achieved by 50–64% of countries, 35–41% of countries would achieve the 2030 target for maternal mortality, 74–90% of countries would meet the goal for tuberculosis mortality, and 66–82% of countries would achieve the target for HIV mortality. Interpretation: Historical rates of decline can help define realistic targets for Sustainable Development Goals. The gap between targets and projected achievement based on recent trends suggests that countries and the international community must seek further acceleration of progress in mortality. Funding: Bill & Melinda Gates Foundation, NORAD.
first_indexed 2024-12-10T18:57:45Z
format Article
id doaj.art-d41d15f7abae4f08afee98c65d051cbe
institution Directory Open Access Journal
issn 2214-109X
language English
last_indexed 2024-12-10T18:57:45Z
publishDate 2014-12-01
publisher Elsevier
record_format Article
series The Lancet Global Health
spelling doaj.art-d41d15f7abae4f08afee98c65d051cbe2022-12-22T01:37:07ZengElsevierThe Lancet Global Health2214-109X2014-12-01212e698e70910.1016/S2214-109X(14)70316-XAnnual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goalsDr. Stéphane Verguet, PhD0Prof. Ole Frithjof Norheim, PhD1Zachary D Olson, MA2Gavin Yamey, MD3Prof. Dean T Jamison, PhD4Department of Global Health, University of Washington, Seattle, WA, USADepartment of Global Public Health and Primary Health Care, University of Bergen, Bergen, NorwayDepartment of Global Health, University of Washington, Seattle, WA, USAGlobal Health Sciences, University of California at San Francisco, San Francisco, CA, USAGlobal Health Sciences, University of California at San Francisco, San Francisco, CA, USABackground: Measuring a country's health performance has focused mostly on estimating levels of mortality. An alternative is to measure rates of decline in mortality, which are more sensitive to changes in health policy than are mortality levels. Historical rates of decline in mortality can also help test the feasibility of future health goals (eg, post-2015). We aimed to assess the annual rates of decline in under-5, maternal, tuberculosis, and HIV mortality over the past two decades for 109 low-income and middle-income countries. Methods: For the period 1990–2013, we estimated annual rates of decline in under-5 mortality (deaths per 1000 livebirths), the maternal mortality ratio (deaths per 100 000 livebirths), and tuberculosis and HIV mortality (deaths per 100 000 population per year) using published data from UNICEF and WHO. For every 5-year interval (eg, 1990–95), we defined performance as the size of the annual rate of decline for every mortality indicator. Subsequently, we tested the feasibility of post-2015 goals by estimating the year by which countries would achieve 2030 targets proposed by The Lancet's Commission on Investing in Health (ie, 20 deaths per 1000 for under-5 mortality, 94 deaths per 100 000 for maternal mortality, four deaths per 100 000 for tuberculosis mortality, and eight deaths per 100 000 for HIV mortality) at observed country and aspirational best-performer (90th percentile) rates. Findings: From 2005 to 2013, the mean annual rate of decline in under-5 mortality was 4·3% (95% uncertainty interval [UI] 3·9–4·6), for maternal mortality it was 3·3% (2·5–4·1), for tuberculosis mortality 4·1% (2·8–5·4), and for HIV mortality 2·2% (0·1–4·3); aspirational best-performer rates per year were 7·1% (6·8–7·5), 6·3% (5·5–7·1), 12·8% (11·5–14·1), and 15·3% (13·2–17·4), respectively. The top two country performers were Macedonia and South Africa for under-5 mortality, Belarus and Bulgaria for maternal mortality, Uzbekistan and Macedonia for tuberculosis mortality, and Namibia and Rwanda for HIV mortality. At aspirational rates of decline, The Lancet's Commission on Investing in Health target for under-5 mortality would be achieved by 50–64% of countries, 35–41% of countries would achieve the 2030 target for maternal mortality, 74–90% of countries would meet the goal for tuberculosis mortality, and 66–82% of countries would achieve the target for HIV mortality. Interpretation: Historical rates of decline can help define realistic targets for Sustainable Development Goals. The gap between targets and projected achievement based on recent trends suggests that countries and the international community must seek further acceleration of progress in mortality. Funding: Bill & Melinda Gates Foundation, NORAD.http://www.sciencedirect.com/science/article/pii/S2214109X1470316X
spellingShingle Dr. Stéphane Verguet, PhD
Prof. Ole Frithjof Norheim, PhD
Zachary D Olson, MA
Gavin Yamey, MD
Prof. Dean T Jamison, PhD
Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals
The Lancet Global Health
title Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals
title_full Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals
title_fullStr Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals
title_full_unstemmed Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals
title_short Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals
title_sort annual rates of decline in child maternal hiv and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013 an assessment of the feasibility of post 2015 goals
url http://www.sciencedirect.com/science/article/pii/S2214109X1470316X
work_keys_str_mv AT drstephaneverguetphd annualratesofdeclineinchildmaternalhivandtuberculosismortalityacross109countriesoflowandmiddleincomefrom1990to2013anassessmentofthefeasibilityofpost2015goals
AT profolefrithjofnorheimphd annualratesofdeclineinchildmaternalhivandtuberculosismortalityacross109countriesoflowandmiddleincomefrom1990to2013anassessmentofthefeasibilityofpost2015goals
AT zacharydolsonma annualratesofdeclineinchildmaternalhivandtuberculosismortalityacross109countriesoflowandmiddleincomefrom1990to2013anassessmentofthefeasibilityofpost2015goals
AT gavinyameymd annualratesofdeclineinchildmaternalhivandtuberculosismortalityacross109countriesoflowandmiddleincomefrom1990to2013anassessmentofthefeasibilityofpost2015goals
AT profdeantjamisonphd annualratesofdeclineinchildmaternalhivandtuberculosismortalityacross109countriesoflowandmiddleincomefrom1990to2013anassessmentofthefeasibilityofpost2015goals